The aim of this study is to prove the improvement of pubo-femoral distance by early abduction
splintage in one-month-old infants with developmental dysplasia of the hip (with a clinical
stable hip but an abnormal hip ultrasonography).
Device: Abduction splintage
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02885831
Ages eligible for Study
1 Months to 2 Months
Genders eligible for Study
Accepts Healthy Volunteers
Infants between 1 and 2 months of age at inclusion
Clinically stable hip
Pathological ultrasonography : pubo-femoral distance >6mm and bony rim percentage <50%
Non objection of the family
Clinically unstable hip
Postural deformity of the pelvis
All locations for NCT02885831
CHRU de Brest
Brest, France, 29609
Put me in touch!
View full eligibility
Tris trial is registered with FDA with number: NCT02885831. The sponsor of the trial is University Hospital, Brest and it is looking for 90 volunteers for the current phase.
Official trial title: Early Abduction Splintage on Stable Hips in Infants With Developmental Dysplasia of the Hip : Improvement or Overtreatment ?
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.